- I pazienti HIV+ manifestano solitamente una psoriasi con elementi clinici più severi e un decorso recidivante.
- Inoltre, la gestione terapeutica nei soggetti HIV+ è complessa e richiede una collaborazione con l’infettivologo.
Abstract
Psoriasis is a immune-mediated, chronic, inflammatory skin dis-ease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic man-agement of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab.